-
If ED physicians and nurses could choose only one strategy for avoiding lawsuits, it should be to keep patient satisfaction levels high, say several experts interviewed by ED Management.
-
Several EDs have introduced physician scribes to free up doctors to spend more time with their patients, but most of those departments use paper charting. At Tri-City Medical Center in Oceanside, CA, physician scribes work within the context of an electronic medical record (EMR).
-
With a vaccine shortage projected for novel H1N1 influenza A, only the highest priority groups are likely to be offered the shot when initial lots are cleared for distribution this fall.
-
The board that oversees New York state's $600 million stem cell research program will allow researchers to pay compensation to women who donate eggs for research a decision believed to be the first in the U.S. to allow state research money for this purpose.
-
It could be months before IRBs in New York state may see any protocols calling for compensation of women who donate eggs for stem cell research.
-
The use of proxy consent for adults who lack the capacity to consent on their own is a complicated issue, thanks to vague and often inadequate state laws describing who can make such decisions.
-
When a human subjects protection program wants to ensure that participants have a confidential means of reporting concerns about studies, one alternative is a commercial "whistleblower" hotline service, which provides anonymity to callers.
-
Research enterprises rarely offer staff ethics consultation services, although a clinical ethics consultation service commonly is offered in hospitals to physicians.
-
A new online decision tree for reporting unanticipated problems (UPs) and serious adverse events (SAEs) has helped a research ethics office reduce unnecessary paperwork and reports and improved compliance with the institution's policies and federal regulations, an IRB compliance coordinator says.
-
The U.S. Food and Drug Administration (FDA) published two final rules on Aug. 13, 2009, detailing how seriously ill patients might gain access to investigational new drugs.
